Zobrazeno 1 - 10
of 120
pro vyhledávání: '"D. Cellier"'
Autor:
J. Fayette, C. Dalban, P. Zrounba, S. Racadot, D. Girodet, S. Chabaud, E. Reyt, M. Poupart, J.M. Prades, M. Burgy, D. Cellier, P. Ceruse, J. Leval, P. Muller, P. Manipoud, I.L. Ray-Coquard, G. Thibault
Publikováno v:
Annals of Oncology. 33:S850-S851
Autor:
W. G. Kim, Daniele Garbin, D. Cellier, Robin Degraeve, Sergiu Clima, S. Kabuyanagi, Mahendra Pakala, A. Cockburn, G. L. Donadio, Andrea Fantini, Wouter Devulder, Gouri Sankar Kar, M. Suzuki, Ludovic Goux, Romain Delhougne
Publikováno v:
2020 IEEE Symposium on VLSI Technology.
Switching mechanism and its controllability in Ovonic Threshold Switching (OTS) devices are systematically investigated by using Si-Ge-As-Se quaternary system known as promising OTS materials. We newly demonstrate that selector device performance is
Autor:
Wouter Devulder, Romain Delhougne, W. G. Kim, Andrea Fantini, Gouri Sankar Kar, Sergiu Clima, Christophe Detavernier, A. Cockburn, Mahendra Pakala, Robin Degraeve, Ludovic Goux, Karl Opsomer, G. L. Donadio, D. Cellier, Daniele Garbin
Publikováno v:
2019 IEEE International Electron Devices Meeting (IEDM).
In this work we explore the composition space of the Ovonic Threshold Switch (OTS) selector device based on Si-Ge-As-Te material system. Physical Vapor Deposition (PVD) co-sputtering capabilities enabled the tuning of the As/Te ratio, Ge and Si conte
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann, M. Aoustin, C. Atlani, F. Bassompierre, R. Benamouzig, M.-J. Bonavita, L. Borella, F. Calvo, C. Caulin, D. Cellier, M. Dahan, V. Daura, F. De Beels, N. De Vernejoul, V. Diebolt, N. Dumarcet, I. Durand Zaleski, E. Fery Lemonnier, J. Genève, I. Giri, D. Golinelli, C. Labreveux, J.-F. Latour, D. Maraninchi, V. Meresse, L. Mignot, D. Morlet, S. Pépin, P. Ravaud, C. Riché, A. Rouleau, P. Tilleul, P. Viens
Publikováno v:
Therapie. 61(4)
Drugs used in oncology represent more than half of the innovative and costly drugs which are not covered by a Group Homogene de Soins (DRG type classification) within the context of the case-mix based payment system (termed T2A). For these drugs, goo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann, M. Aoustin, C. Atlani, F. Bassompierre, R. Benamouzig, M.-J. Bonavita, L. Borella, F. Calvo, C. Caulin, D. Cellier, M. Dahan, V. Daura, F. De Beels, N. De Vernejoul, V. Diebolt, N. Dumarcet, I. Durand Zaleski, E. Fery Lemonnier, J. Genève, I. Giri, D. Golinelli, C. Labreveux, J.-F. Latour, D. Maraninchi, V. Meresse, L. Mignot, D. Morlet, S. Pépin, P. Ravaud, C. Riché, A. Rouleau, P. Tilleul, P. Viens
Publikováno v:
Therapies. 61:305-308
Les medicaments utilises en cancerologie representent plus de la moitie des medicaments innovants et couteux pris en charge hors d'un groupe homogene de soins dans le cadre de la tarification a l'activite. Pour ces medicaments, des referentiels de bo
Autor:
Muriel Vray, Bernard Hamelin, Patrice Jaillon, M. Andréjak, R. Benamouzig, J.-P. Boissel, C. Bremard-Oury, C. Brun-Strang, E. Caulin, D. Cellier, D. Costagliola, V. Daurat, A. El Hasnaoui, J.-M. Goehrs, B. Hamelin, P. Jaillon, C. Jouan-Flahault, J.-L. Montastruc, N. Moore, A. Puech, M. Ricatte, P. Ricordeau, M.-H. Rodde-Dunet, E. Rouffiac, T. Simon, P. Simon, A. Spriet, E. Van Ganse, P. Velicitat, M. Vray
Publikováno v:
Therapies. 60:345-349
The respective roles of controlled clinical trials and observational studies (cohort or case-control studies) in evaluating the efficacy, safety and usefulness of a drug were analysed. A randomised, controlled, double-blind study is the best method o
Autor:
P. Jaillon, E. Caulin, M. Vray, E. Van Ganse, Alain J. Puech, E. Rouffiac, Jean-Pierre Boissel, Jean-Marie Goehrs, M. Ricatte, D. Cellier, C. Brun-Strang, P. Simon, Patrice Jaillon, A. Spriet, Chrystel Jouan-Flahault, M.-H. Rodde-Dunet, Michel Andrejak, Bernard Hamelin, B. Hamelin, Muriel Vray, Tabassome Simon, J. L. Montastruc, Dominique Costagliola, A El Hasnaoui, P. Ricordeau, C. Bremard-Oury, P. Velicitat, Robert Benamouzig, V. Daurat, Nicholas Moore
Publikováno v:
Therapies. 60:339-344
Resume La place relative des essais cliniques comparatifs et des etudes observationnelles (cohortes ou etudes castemoins) a ete etudiee dans l’objectif d’evaluer l’efficacite, la tolerance et l’interet de sante publique d’un medicament. L
Autor:
Yannick Plétan, Faïez Zannad, Patrice Jaillon, E. Autret-Leca, Ch. Belorgey, M. Bernard-Harlaut, D. Cellier, F. Chazelle, M.F. Chevallier-Le Guyader, M. Couderc, D. Debiais, J. D’Enfert, A.M. Duguet, L. Fleury, M. Gallard, A. Giacomino, Y. Juillet, H. Kolsky, J.P. Lehner, F. Lemaire, M.F. Padioleau, M. Peschanski, S. Ravoire, J.P. Reynier, Ph. Ricordeau, P. Sassano, C. Sibenaler, M.C. Simon, J. Soletti
Publikováno v:
Therapies. 58:197-208
Be it to restore the confused image of clinical research in relation to the lay public, or to develop new ways of accruing healthy volunteers or patients for clinical trials, there is a need to draft some guidance on how best to provide information o